Comparison of the left ventricular electromechanical map before percutaneous coronary stent revascularization and at one-month follow-up in patients with a recent ST elevation infarction
- 27 January 2005
- journal article
- research article
- Published by Wiley in Catheterization and Cardiovascular Interventions
- Vol. 64 (2) , 153-159
Abstract
The study aimed to evaluate the safety and potential of percutaneous transluminal electromechanical mapping (NOGA) in patients with regional myocardial wall dysfunction after a recent ST elevation myocardial infarction (STEMI). Regional myocardial wall dysfunction is a major cause of morbidity in survivors of ST elevation myocardial infarction. Fifteen males who recently had suffered a STEMI were studied prospectively with coronary angiography, ventriculography, and NOGA before and 1 month after percutaneous coronary intervention (PCI). The left ventricular angiographic ejection fraction increased from 50% ± 11% before PCI to 56% ± 10% at follow‐up (P = 0.006). Qualitative analysis of the NOGA color map identified and outlined an area of regional wall dysfunction in all patients. Quantitative analysis of the NOGA maps showed improvements at follow‐up after PCI in regional wall parameters of the infarct area (bipolar voltage: 1.7 ± 1.4 mV before intervention, 2.2 ± 1.6 mV at follow‐up, P = 0.05; local shortening, a NOGA parameter on wall motion: 3.5% ± 6.2% before, 7.4% ± 5.8% at follow‐up, P = 0.01), whereas there were no changes in the noninfarcted area (bipolar voltage: 2.7 ± 2.5 mV before intervention, 2.8 ± 2.6 mV at follow‐up, P = 0.99; local shortening: 7.8% ± 7.8% before, 8.2% ± 7.8% at follow‐up, P = 0.99). There were no complications to the NOGA procedures. In patients treated with PCI for a recent STEMI, NOGA might be considered used in the quantification of myocardial recovery and in the outlining of myocardial areas of incomplete or no recovery. Catheter Cardiovasc Interv 2005;64:153–159.Keywords
Funding Information
- Cordis Scandinavia
This publication has 27 references indexed in Scilit:
- Direct intramyocardial plasmid vascular endothelial growth factor-A165gene therapy in patients with stable severe angina pectorisJACC, 2005
- Transendocardial, Autologous Bone Marrow Cell Transplantation for Severe, Chronic Ischemic Heart FailureCirculation, 2003
- Electromechanical mapping for determination of myocardial contractility and viability: A comparison with echocardiography, myocardial single-photon emission computed tomography, and positron emission tomographyJACC, 2002
- Evidence That Human Cardiac Myocytes Divide after Myocardial InfarctionNew England Journal of Medicine, 2001
- Electromagnetic guidance for catheter-based transendocardial injection: a platform for intramyocardial angiogenesis therapyJACC, 2000
- Prediction of recovery of myocardial dysfunction after revascularization comparison of fluorine-18 fluorodeoxyglucose/thallium-201 SPECT, thallium-201 stress-reinjection SPECT and dobutamine echocardiographyJACC, 1996
- A Clinical Trial of the Angiotensin-Converting–Enzyme Inhibitor Trandolapril in Patients with Left Ventricular Dysfunction after Myocardial InfarctionNew England Journal of Medicine, 1995
- Improvement of global and regional left ventricular function by percutaneous transluminal coronary angioplasty after myocardial infarctionJACC, 1995
- Effect on global and regional left ventricular functions by percutaneous transluminal coronary angioplasty in the chronic stage after myocardial infarctionThe American Journal of Cardiology, 1992
- Reversibility of Cardiac Wall-Motion Abnormalities Predicted by Positron TomographyNew England Journal of Medicine, 1986